Completed
Phase 2
Age: 21Years - 51Years
All Genders
ID00000191
Carbamazepine Treatment for Cocaine Dependence
Led by University of Pennsylvania · Updated on 2015-05-28
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Pennsylvania
Lead Sponsor
N
National Institute on Drug Abuse (NIDA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.
CONDITIONS
Brief Title
Carbamazepine Treatment for Cocaine Dependence - 5
Who Can Participate
Age: 21Years - 51Years
All Genders
Eligibility Criteria
Please contact site for information.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here